Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Apr 12, 2023
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pear Therapeutics, Inc.
| -16.54M |
$0.12 | -$1,985,293.56 | -98.81% | 200K |
Apr 10
| |||||||
Pear Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 |
Feb 15 - Feb 16
| ||||||
Pear Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 15
| |||||||
Pear Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| +2 |
Feb 15
| ||||||
Pear Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 15
| |||||||
Pear Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 15
| |||||||
Pear Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| +3 |
Feb 15
| ||||||
Pear Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 15
| |||||||
Pear Therapeutics, Inc.
| 52.38K |
—
|
—
|
∞
| 52.38K |
Feb 15
| |||||||
Pear Therapeutics, Inc.
| 66.67K |
—
|
—
|
∞
| 66.67K |
Feb 15
| |||||||
Pear Therapeutics, Inc.
| 61.9K |
—
|
—
|
∞
| 61.9K |
Feb 15
| |||||||
Pear Therapeutics, Inc.
| 52.38K |
—
|
—
|
∞
| 52.38K |
Feb 15
| |||||||
Pear Therapeutics, Inc.
| 52.38K |
—
|
—
|
∞
| 52.38K |
Feb 15
| |||||||
Pear Therapeutics, Inc.
| 71.43K |
—
|
—
|
∞
| 71.43K |
Feb 15
| |||||||
Pear Therapeutics, Inc.
| -12.16K |
$1.13 | -$13,743.06 | -39.49% | 18.64K | +1 |
Jan 20
| ||||||
Pear Therapeutics, Inc.
| -8.03K |
$1.13 | -$9,070.51 | -25.61% | 23.32K |
Jan 20
| |||||||
Pear Therapeutics, Inc.
| -12.69K |
$1.13 | -$14,337.44 | -30.72% | 28.61K |
Jan 20
| |||||||
Pear Therapeutics, Inc.
| -8.69K |
$1.13 | -$9,819.70 | -16.71% | 43.31K |
Jan 20
| |||||||
Pear Therapeutics, Inc.
| -19.54K |
$1.13 | -$22,080.20 | -39.47% | 29.96K | +3 |
Jan 20
| ||||||
Pear Therapeutics, Inc.
| -7.10K |
$1.13 | -$8,018.48 | -46.08% | 8.3K |
Jan 20
| |||||||
Pear Therapeutics, Inc.
| -12.16K |
$1.13 | -$13,743.06 | -11.42% | 94.33K |
Jan 20
| |||||||
Pear Therapeutics, Inc.
| -34.73K |
$1.13 | -$39,246.03 | -0.42% | 8.21M |
Jan 20
| |||||||
Pear Therapeutics, Inc.
| 22K |
—
|
—
| +73.33% | 52K |
Jan 14
| |||||||
Pear Therapeutics, Inc.
| 30.8K |
—
|
—
| +40.69% | 106.5K |
Jan 14
| |||||||
Pear Therapeutics, Inc.
| 88K |
—
|
—
| +1.08% | 8.25M |
Jan 14
| |||||||
Pear Therapeutics, Inc.
| 49.5K |
—
|
—
|
∞
| 49.5K | +3 |
Jan 14
| ||||||
Pear Therapeutics, Inc.
| 20.32K |
—
|
—
| +184.31% | 31.34K |
Jan 14
| |||||||
Pear Therapeutics, Inc.
| 33K |
—
|
—
| +397.59% | 41.3K |
Jan 14
| |||||||
Pear Therapeutics, Inc.
| 30.8K |
—
|
—
|
∞
| 30.8K | +1 |
Jan 14
| ||||||
Pear Therapeutics, Inc.
| 15.4K |
—
|
—
|
∞
| 15.4K |
Jan 14
| |||||||
Pear Therapeutics, Inc.
| -430.00K |
—
|
—
| -6.57% | 6.11M |
Dec 9
| |||||||
Pear Therapeutics, Inc.
| 15K |
$1.00 | $15,000.00 | +100.00% | 30K |
Dec 9
| |||||||
Pear Therapeutics, Inc.
| -105.28K |
$2.74 | -$288,267.28 | -0.78% | 13.37M |
Nov 11 - Nov 15
| |||||||
Pear Therapeutics, Inc.
| -54.21K |
$2.77 | -$150,095.68 | -0.40% | 13.48M |
Oct 31 - Nov 2
| |||||||
Pear Therapeutics, Inc.
| -558.17K |
$1.88 | -$1,047,321.73 | -3.96% | 13.53M |
Sep 14 - Sep 16
| |||||||
Pear Therapeutics, Inc.
| -770.00K |
$2.05 | -$1,581,834.98 | -5.18% | 14.09M |
Sep 6 - Sep 8
| |||||||
Pear Therapeutics, Inc.
| -400.00K |
$1.65 | -$660,059.58 | -2.62% | 14.86M |
Aug 16 - Aug 18
| |||||||
Pear Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 14
| |||||||
Pear Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 14
| |||||||
Pear Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 14
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. |
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.